Haya Therapeutics’ CHF 18 Million Seed Round

VISCHER advised Haya Therapeutics SA on all legal issues related to the financing round.HAYA Therapeutics SA, a company developing precision medicines that target tissue and cell-specific…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here